Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Total Liabilities
Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has total liabilities worth CN¥3.77 Billion CNY (≈ $552.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Yantai Dongcheng Pharmaceutical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Yantai Dongcheng Pharmaceutical Co Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 002675 total assets.
Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kelt Exploration Ltd.
TO:KEL
|
Canada | CA$477.39 Million |
|
SKYWORTH GRP UNSP.ADR/30
F:KYW0
|
Germany | €53.44 Billion |
|
Virgin Australia Holdings Ltd
AU:VGN
|
Australia | AU$5.69 Billion |
|
Sunonwealth Electric Machine Industry Co Ltd
TW:2421
|
Taiwan | NT$8.10 Billion |
|
Kyland Technology Co Ltd
SHE:300353
|
China | CN¥1.86 Billion |
|
BlackRock Capital Allocation Trust
NYSE:BCAT
|
USA | $370.43 Million |
|
Ardent Health Partners, Inc.
NYSE:ARDT
|
USA | $3.54 Billion |
|
Avi Ltd
JSE:AVI
|
South Africa | ZAC5.15 Billion |
Liability Composition Analysis (2008–2025)
This chart breaks down Yantai Dongcheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 002675 net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yantai Dongcheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual total liabilities of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.61 Billion ≈ $527.75 Million |
+10.52% |
| 2024-12-31 | CN¥3.26 Billion ≈ $477.51 Million |
+21.46% |
| 2023-12-31 | CN¥2.69 Billion ≈ $393.15 Million |
-7.18% |
| 2022-12-31 | CN¥2.89 Billion ≈ $423.57 Million |
+9.96% |
| 2021-12-31 | CN¥2.63 Billion ≈ $385.22 Million |
+8.44% |
| 2020-12-31 | CN¥2.43 Billion ≈ $355.23 Million |
-3.52% |
| 2019-12-31 | CN¥2.52 Billion ≈ $368.18 Million |
+6.76% |
| 2018-12-31 | CN¥2.36 Billion ≈ $344.86 Million |
+18.76% |
| 2017-12-31 | CN¥1.98 Billion ≈ $290.38 Million |
+67.61% |
| 2016-12-31 | CN¥1.18 Billion ≈ $173.25 Million |
+279.54% |
| 2015-12-31 | CN¥311.94 Million ≈ $45.65 Million |
+49.21% |
| 2014-12-31 | CN¥209.06 Million ≈ $30.59 Million |
+64.39% |
| 2013-12-31 | CN¥127.18 Million ≈ $18.61 Million |
+74.59% |
| 2012-12-31 | CN¥72.84 Million ≈ $10.66 Million |
-50.38% |
| 2011-12-31 | CN¥146.82 Million ≈ $21.48 Million |
-12.68% |
| 2010-12-31 | CN¥168.14 Million ≈ $24.60 Million |
+32.88% |
| 2009-12-31 | CN¥126.53 Million ≈ $18.52 Million |
+9.32% |
| 2008-12-31 | CN¥115.74 Million ≈ $16.94 Million |
-- |
About Yantai Dongcheng Pharmaceutical Co Ltd
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more